An Animated Whiteboard Online View of Biological Agents for the Treatment of Systemic Lupus Erythematosus

Target Audience
This activity is designed to meet the educational needs of U.S.-based rheumatologists and other healthcare professionals involved in the management of patients with SLE. We aim to educate and offer multiple resources to more than 3000 of the targeted practitioners.

Program Overview
This activity targets healthcare gaps related to the identification and understanding of potential therapeutic targets for treating systemic lupus erythematous (SLE), impacting SLE management and potential utilization of targeted treatment.

By addressing these gaps, you can assess whether your treatment approaches to SLE include considering the use of biologic agents in addition to corticosteroids and immunosuppressants, allowing modifications of treatment approaches to help close these gaps.
Expert discussion will guide you in identifying potential pathophysiologic targets, deciding whether treatment with biologic agents is indicated, and utilizing clinical trial data and algorithms to guide treatment approaches based on disease severity.
You will also be immersed in dynamic animations utilizing a whiteboard platform to memorably highlight key points related to disease pathophysiology as it relates to the role of interferons and biologic agents targeting the interferon alpha receptor.
Learning Objectives
Upon completion of this activity, participants should be better able to:

Examine the roles of IFNs in the pathophysiology of SLE and how new findings can inform potential therapeutic targets;
Identify the mechanisms of action of FDA-approved and emerging biological treatment options for patients with SLE; and
Discuss challenges in developing novel biologic therapies for SLE owing to a lack of clearly defined clinical trial efficacy endpoints.